Multidrug-Resistant Candida haemulonii and C. auris, Tel Aviv, Israel

Emerging Infectious Diseases
Ronen Ben-AmiTalya Finn

Abstract

Candida auris and C. haemulonii are closely related, multidrug-resistant emerging fungal pathogens that are not readily distinguishable with phenotypic assays. We studied C. auris and C. haemulonii clinical isolates from 2 hospitals in central Israel. C. auris was isolated in 5 patients with nosocomial bloodstream infection, and C. haemulonii was found as a colonizer of leg wounds at a peripheral vascular disease clinic. Liberal use of topical miconazole and close contact among patients were implicated in C. haemulonii transmission. C. auris exhibited higher thermotolerance, virulence in a mouse infection model, and ATP-dependent drug efflux activity than C. haemulonii. Comparison of ribosomal DNA sequences found that C. auris strains from Israel were phylogenetically distinct from isolates from East Asia, South Africa and Kuwait, whereas C. haemulonii strains from different countries were closely interrelated. Our findings highlight the pathogenicity of C. auris and underscore the need to limit its spread.

References

Dec 6, 1996·The Journal of Biological Chemistry·M KolaczkowskiA Goffeau
Aug 25, 1999·The Journal of Antimicrobial Chemotherapy·S MaesakiS Kohno
Mar 23, 2004·Nucleic Acids Research·Robert C Edgar
Jun 8, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kevin W GareyDavid T Bearden
Aug 16, 2006·Annals of Internal Medicine·Andrew S LeveyUNKNOWN Chronic Kidney Disease Epidemiology Collaboration
Feb 6, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Mi-Na KimDong Wook Ryang
Sep 30, 2009·International Journal of Antimicrobial Agents·Sheng-Yuan RuanPo-Ren Hsueh
Jul 1, 2011·Journal of Clinical Microbiology·Wee Gyo LeeHee-Chang Jang
Mar 14, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David R AndesUNKNOWN Mycoses Study Group
Mar 29, 2012·Proceedings of the National Academy of Sciences of the United States of America·Conrad L SchochUNKNOWN Fungal Barcoding Consortium Author List
Mar 15, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Barbara D AlexanderMichael A Pfaller
Sep 21, 2013·Emerging Infectious Diseases·Anuradha ChowdharyJacques F Meis
Dec 21, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A ChowdharyJ F Meis
Mar 29, 2014·The New England Journal of Medicine·Shelley S MagillUNKNOWN Emerging Infections Program Healthcare-Associated Infections and Antimicrobial Use Prevalence Survey Team
Jun 26, 2014·Emerging Infectious Diseases·Rindidzani E MagoboNelesh P Govender
Aug 20, 2014·The Journal of Antimicrobial Chemotherapy·Lívia S RamosAndré L S Santos
Sep 9, 2015·BMC Genomics·Sharanya ChatterjeeUtpal S Tatu
Oct 9, 2015·The New England Journal of Medicine·Bart Jan Kullberg, Maiken C Arendrup
Feb 20, 2016·Emerging Infectious Diseases·João Nobrega de AlmeidaGil Benard
Mar 24, 2016·Molecular Biology and Evolution·Sudhir KumarKoichiro Tamura

❮ Previous
Next ❯

Citations

Jul 8, 2017·Mycoses·Jalila MohsinAbdullah M S Al-Hatmi
Feb 7, 2018·Current Infectious Disease Reports·Ilan S Schwartz, Thomas F Patterson
Jan 27, 2018·Journal of Fungi·Ryan KeanGordon Ramage
Mar 30, 2018·Emerging Microbes & Infections·Johanna RhodesSilke Schelenz
May 16, 2018·Annals of the New York Academy of Sciences·Jennifer Geddes-McAlister, Rebecca S Shapiro
Nov 22, 2017·Antimicrobial Agents and Chemotherapy·Ruvini U PathiranaMira Edgerton
Apr 11, 2018·Antimicrobial Agents and Chemotherapy·Milena KordalewskaDavid S Perlin
Nov 17, 2017·Clinical Microbiology Reviews·Anna Jeffery-SmithColin S Brown
Jun 8, 2018·Current Opinion in Infectious Diseases·Katja SarisAndreas Voss
Nov 24, 2017·Journal of Clinical Microbiology·Emily S Spivak, Kimberly E Hanson
Aug 18, 2018·Journal of Fungi·Ronen Ben-Ami
Aug 30, 2017·Antimicrobial Agents and Chemotherapy·Hamed FakhimHamid Badali
Jun 7, 2017·Antimicrobial Agents and Chemotherapy·Alexander J LepakDavid R Andes
Nov 21, 2017·F1000Research·Anna SkiadaMaria Drogari-Apiranthitou
Feb 6, 2019·Antimicrobial Agents and Chemotherapy·Jeffrey M RybakP David Rogers
May 14, 2019·The Journal of Antimicrobial Chemotherapy·Catiana DudiukGuillermo Garcia-Effron
Feb 19, 2019·Mycoses·Shabir A Lone, Aijaz Ahmad
Jun 22, 2019·The Journal of Antimicrobial Chemotherapy·Sebastian WursterDimitrios P Kontoyiannis
Jul 22, 2019·The Journal of Antimicrobial Chemotherapy·Shivaprakash M RudramurthyArunaloke Chakrabarti
Oct 28, 2019·Journal of Fungi·Amal Al MaaniAbdullah M S Al-Hatmi
Oct 28, 2019·Current Topics in Medicinal Chemistry·Laura Nunes SilvaAndré Luis Souza Dos Santos
Mar 1, 2020·Journal of Fungi·Ryan KeanGordon Ramage
Apr 3, 2020·Expert Review of Anti-infective Therapy·Arunaloke Chakrabarti, Shreya Singh
Oct 17, 2019·MBio·Lohith KunyeitReeta P Rao
Jul 10, 2020·Pathogens and Disease·Taissa VilaMary Ann Jabra-Rizk
Jun 3, 2020·Antimicrobial Agents and Chemotherapy·Laís Salomão AriasJason L Brown
Jun 7, 2019·Archives of Pathology & Laboratory Medicine·D Jane HataUNKNOWN College of American Pathologists Microbiology Committee
Feb 2, 2018·The Journal of Infectious Diseases·Frederic Lamoth, Dimitrios P Kontoyiannis
Jan 12, 2019·Frontiers in Microbiology·Luana Rossato, Arnaldo Lopes Colombo

❮ Previous
Next ❯

Datasets Mentioned

BETA
CBS10913

Methods Mentioned

BETA
PCR

Software Mentioned

MUSCLE
Vitek

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
R P Wenzel, M A Pfaller
Emerging Infectious Diseases
Maha EmaraRitu Bafna
© 2022 Meta ULC. All rights reserved